Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity. (Q35758593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Edward Peres

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Roger Dansey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Muneer H Abidi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Esteban M Abella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jared Klein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

27 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

Annals of Pharmacotherapy

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1053-1059

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

Allogeneic hematopoietic stem cell transplantation: complications and results

27 December 2019

cites work

1 reference

Veno-occlusive disease of the liver

21 January 2018

1 reference

Prevention and treatment of veno-occlusive disease

21 January 2018

1 reference

The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches

21 January 2018

1 reference

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

21 January 2018

1 reference

Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation.

21 January 2018

1 reference

Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation

21 January 2018

1 reference

Antithrombin III in hematopoietic stem cell transplantation

21 January 2018

1 reference

Veno-occlusive disease: cytokines, genetics, and haemostasis

21 January 2018

1 reference

Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation

21 January 2018

1 reference

Multiple organ dysfunction syndrome in bone marrow transplantation

21 January 2018

1 reference

Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients

21 January 2018

1 reference

Clinical trial results with antithrombin III in sepsis

21 January 2018

1 reference

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.

21 January 2018

1 reference

A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.

21 January 2018

1 reference

Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer

21 January 2018

1 reference

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

21 January 2018

1 reference

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin

21 January 2018

1 reference

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

21 January 2018

1 reference

Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113990%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference